Added to YB: 2023-10-23
Pitch date: 2023-10-23
AMAM:US [bullish]
Ambrx Biopharma Inc.
+240.22%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Ambrx (Nasdaq: AMAM) is a clinical stage biopharmaceutical company that specializes in the discovery and development of next generation antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system.
Market Cap
$1.8B
Pitch Price
$8.23
Price Target
N/A
Dividend
N/A
EV/EBITDA
-27.21
P/E
-117.80
EV/Sales
380.92
Sector
Biotechnology
Category
N/A
Show full summary:
Ambrx Biopharma, Inc. AMAM:US
A summary for this pitch has not been created yet.
Read full article (0 min)